Readmission Risk Factors and Heart Failure With Preserved Ejection Fraction

NCT04008914 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 492

Last updated 2019-07-08

No results posted yet for this study

Summary

Retrospective review of 492 patient from a small community hospital who did not qualify for participation in the Connect HF study sponsored by DCRI.

Conditions

Interventions

OTHER

retrospective observation

Retrospective review of study patients excluded from the CONNECT- HF trial who were discharged with a diagnosis of HFpEF between August 1, 2017 and March 1, 2018. Readmission rate at 30 and 90 days along with patient demographics and associated comorbidities were analyzed.

Sponsors & Collaborators

  • Ascension Macomb-Oakland Hospital

    lead OTHER

Principal Investigators

  • Dustin Harmon, DO · Ascension Macomb-Oakland Hospital

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-08-01
Primary Completion
2018-03-01
Completion
2019-01-18

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04008914 on ClinicalTrials.gov